Cargando…
Clinically relevant subgroups in COPD and asthma
As knowledge of airways disease has grown, it has become apparent that neither chronic obstructive pulmonary disease (COPD) nor asthma is a simple, easily defined disease. In the past, treatment options for both diseases were limited; thus, there was less need to define subgroups. As treatment optio...
Autores principales: | Turner, Alice M., Tamasi, Lilla, Schleich, Florence, Hoxha, Mehmet, Horvath, Ildiko, Louis, Renaud, Barnes, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487805/ https://www.ncbi.nlm.nih.gov/pubmed/26028640 http://dx.doi.org/10.1183/16000617.00009014 |
Ejemplares similares
-
Asthma in pregnancy - from immunology to clinical management
por: Tamási, Lilla, et al.
Publicado: (2010) -
Impact of Clinical Factors on Generic and Disease-Specific Quality of Life in COPD and Asthma-COPD Overlap with Exacerbations
por: Lázár, Zsófia, et al.
Publicado: (2020) -
Cytokine-targeted therapies for asthma and COPD
por: Schleich, Florence, et al.
Publicado: (2023) -
Granulocytic Airway Inflammation and Clinical Asthma Outcomes
por: Louis, Renaud E., et al.
Publicado: (2021) -
Effectiveness and Treatment Compliance of Salmeterol–Fluticasone Easyhaler(®) Among Patients with Asthma, COPD, or Asthma–COPD Overlap Syndrome: Real-World Study Findings
por: Tamási, Lilla, et al.
Publicado: (2022)